Who invested in Altair Therapeutics?
Altair Therapeutics's investors include Domain Associates, Forward Ventures, Thomas, McNerney & Partners and GeneChem.
United States · Series B startup
2 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$23Mraised across 2 rounds since 2009, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by onbiovc.comSEC filing: $6.5M sold, first sale Nov 2009
No investor was named in the report.
From a historical funding recordSEC filing: $6.5M sold, first sale Nov 2009
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Altair Therapeutics's investors include Domain Associates, Forward Ventures, Thomas, McNerney & Partners and GeneChem.
Altair Therapeutics has raised $23M across 2 rounds since 2009.
Altair Therapeutics's most recent round was a Series B of $17M in Feb 2010.
Its most recent round, $17M in Feb 2010, is also its largest on record.
Altair Therapeutics's first round on record, in Feb 2010, was backed by Domain Associates, Forward Ventures and Thomas, McNerney & Partners and 1 others.
Altair Therapeutics's latest named round is a Series B, in Feb 2010.
Altair Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.